title: Replacement of homologous mouse DNA sequence with pathogenic 6-base human CREB1 promoter sequence creates murine model of major depressive disorder.
abstract: Major depressive disorder (MDD) is a leading cause of disability worldwide. Families with recurrent, early-onset MDD (RE-MDD), a severe, familial form of MDD, have provided an important resource for identifying and characterizing genetic variants that confer susceptibility to MDD and related disorders. Previous studies identified a rare, highly penetrant A(-115)G transition within the human CREB1 promoter that reduced promoter activity in vitro and was associated with depressive disorders in RE-MDD families. The development of an etiology-based recombinant animal model for MDD would facilitate the advancement of our limited understanding of the pathophysiology of MDD, as well as the development of improved treatments. Here we report the construction and initial characterization of a congenic mutant C57BL/6NTac mouse model that carries the human pathogenic sequence at the homologous position of the mouse Creb1 promoter. The recombinant strain exhibited decreases in reproductive capacity and pup survival that may be related to increased infant mortality observed in RE-MDD families; enlargement of the cerebral ventricles; reduced levels of CREB protein in the mouse cerebral cortex, as predicted from transfection experiments employing the pathogenic human CREB1 promoter; and alterations in two standardized behavioral tests, the forced swim and marble burying tests. These initial findings support the pathogenicity of the human A(-115)G promoter variant, and invite further characterization of this etiology-based recombinant animal model for MDD. Human promoter variants that have highly penetrant effects on disease expression provide an attractive opportunity for creating etiology-based mouse models of human diseases, with minimal disruption of the mouse genome.
authors: Department of Psychiatry, School of Medicine, University of Pittsburgh, Pennsylvania, USA. zubenkog@pitt.edu
authors: George S
authors: GS
authors: Zubenko
authors: Hugh B
authors: HB
authors: Hughes
references: Neuron. 2002 Mar 28;34(1):13-25
references: 11931738
references: Mol Psychiatry. 2003 Jun;8(6):611-8
references: 12851637
references: Nat Genet. 2003 Jan;33(1):85-9
references: 12496759
references: Neuron. 1997 Oct;19(4):755-9
references: 9354323
references: Am J Med Genet. 2001 Dec 8;105(8):690-9
references: 11803516
references: J Inherit Metab Dis. 2002 May;25(3):157-82
references: 12137225
references: Eur J Pharmacol. 2004 Jun 21;494(1):35-44
references: 15194449
references: Mol Psychiatry. 2000 Mar;5(2):131-6
references: 10822339
references: Eur J Pharmacol. 1986 Jul 31;126(3):223-9
references: 2875886
references: Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):10-6
references: 19517574
references: Pharmacol Biochem Behav. 2004 Jun;78(2):269-74
references: 15219767
references: J Steroid Biochem Mol Biol. 2001 Jun;77(4-5):193-203
references: 11457657
references: J Neural Transm Gen Sect. 1990;82(3):219-30
references: 1979003
references: Am J Med Genet. 2002 Mar 8;114(2):214-21
references: 11857584
references: Neurosci Biobehav Rev. 2009 May;33(5):699-771
references: 19428491
references: Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4481-6
references: 9539763
references: Am J Hum Genet. 2006 Jun;78(6):936-46
references: 16685645
references: Am J Med Genet B Neuropsychiatr Genet. 2008 Jul 5;147B(5):579-85
references: 18213625
references: Physiol Behav. 1989 May;45(5):1067-8
references: 2780868
references: Mol Psychiatry. 2002;7(5):460-7
references: 12082563
references: Clin Chem. 2009 Apr;55(4):698-708
references: 19246615
references: Nat Rev Mol Cell Biol. 2001 Aug;2(8):599-609
references: 11483993
references: Eur J Pharmacol. 2004 Jun 21;494(1):45-53
references: 15194450
references: Am J Med Genet B Neuropsychiatr Genet. 2003 Aug 15;121B(1):39-43
references: 12898573
references: Am J Med Genet. 2002 May 8;114(4):413-22
references: 11992563
references: Nature. 1977 Apr 21;266(5604):730-2
references: 559941
references: Nucleic Acids Res. 2001 Jan 1;29(1):281-3
references: 11125113
references: J Steroid Biochem Mol Biol. 2001 Apr;77(1):19-27
references: 11358671
references: Eur J Pharmacol. 1998 Jan 26;342(2-3):177-82
references: 9548383
references: Am J Med Genet. 2002 Dec 8;114(8):980-7
references: 12457397
references: J Neurosci. 2005 Apr 13;25(15):3870-80
references: 15829639
references: Trends Neurosci. 2005 Aug;28(8):436-45
references: 15982754
references: Psychopharmacology (Berl). 1997 Feb;129(3):197-205
references: 9084057
references: Am J Med Genet B Neuropsychiatr Genet. 2010 Dec 5;153B(8):1365-72
references: 20957653
references: Proc Natl Acad Sci U S A. 2004 May 25;101(21):8186-91
references: 15148402
references: Nucleic Acids Res. 2003 Jul 1;31(13):3576-9
references: 12824369
references: Neuron. 2002 Mar 14;33(6):845-8
references: 11906692
references: Exp Anim. 2009 Apr;58(2):141-9
references: 19448337
references: Am J Med Genet B Neuropsychiatr Genet. 2003 Nov 15;123B(1):1-18
references: 14582139
references: Arch Gen Psychiatry. 1986 Nov;43(11):1085-9
references: 3767598
references: J Appl Physiol (1985). 2001 Dec;91(6):2785-801
references: 11717247
references: Mol Psychiatry. 2009 Apr;14(4):390-7
references: 18317463
references: Behav Brain Res. 2002 Nov 15;136(2):489-501
references: 12429412
references: Curr Protoc Neurosci. 2008 Oct;Chapter 9:Unit 9.30
references: 18972380
references: Methods Mol Biol. 2009;561:127-44
references: 19504069
references: Curr Protoc Mol Biol. 2008 Apr;Chapter 23:Unit 23.5
references: 18425764